Day: September 29, 2014

29 Sep 2014

Akebia Announces Dosing of First Patient in Phase 2 Study of AKB-6548 in Patients with Anemia Related to Chronic Kidney Disease Undergoing Dialysis

On September 25, 2014, Akebia Therapeutics, Inc., a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and...

Published on Sep 2014

High complication rate after total knee and hip replacement due to perioperative bridging of anticoagulant therapy based on the 2012 ACCP guideline.

Leijtens B, Kremers van de Hei K, Jansen J, Koeter S

Arch Orthop Trauma Surg 2014;134:1335-1341.

Review by D. Faraoni

Published on Oct 2014

Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: A randomized pilot trial.

Galas FR, de Almeida JP, Fukushima JT, et al.

J Thorac Cardiovasc Surg 2014;148:1647-1655.

Review by D. Faraoni

MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.

Sitemap

Contact us

SUBSCRIBE TO OUR NEWSLETTER

Consent Management Platform by Real Cookie Banner